Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium.

Michele SassanoMartina TaborelliStefania BocciaGabriella CadoniCarlo La VecchiaWerner GaravelloPhilip LazarusYuan-Chin Amy LeeMia HashibePaolo Boffetta

Published in: Head & neck (2024)

This study suggests that aspirin intake may reduce the risk of HNC, driven mainly by decreases in risk for laryngeal and oropharyngeal cancer.

Keyphrases

low dose
cardiovascular events
antiplatelet therapy
papillary thyroid
weight gain
squamous cell carcinoma
type diabetes
cardiovascular disease
acute coronary syndrome
anti inflammatory drugs
physical activity